Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Virtual collaboration

    R:SQD logo

    Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

    Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

    Cuttsy + Cuttsy

    - PMLiVE

    The Future of MSL Training – How Digital Technologies Are Shaping Success

    Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

    Impetus Digital

    - PMLiVE

    Learn the golden standard for omnichannel strategies!

    Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar to learn how to eliminate silos and turn fragmented data into actionable insights. Register...

    Impetus Digital

    - PMLiVE

    Aqilion announces positive results from eosinophilic esophagitis treatment study

    Phase 2 trials for EoE are now expected to be initiated in Europe, Canada and the US

    Report fan imager

    New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

    Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

    Cuttsy + Cuttsy

    - PMLiVE

    Your Blueprint for Flawless Pharma Omnichannel

    Learn how to eliminate silos, transform data into actionable insights, and drive unparalleled efficiency across your key initiatives. Secure your spot in our free webinar, exclusive for life science professionals!

    Impetus Digital

    Build a KOL Community Virtually – Engaging Your Advisors Creatively

    Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your...

    Impetus Digital

    - PMLiVE

    AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

    Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

    Innovative Trials

    Streamline Clinical Trial Collaboration – Engaging Your Advisors Creatively

    Boost efficiency in clinical operations! Learn a creative way to enhance communication between teams at different sites and streamline the development of study protocols, support materials, and journal submissions.

    Impetus Digital

    - PMLiVE

    Novartis to acquire Tourmaline Bio in a deal worth $1.4bn

    Novartis will gain cardiovascular treatment option pacibekitug

    - PMLiVE

    NEW Pharma-exclusive Webinar: From Fragmented to Flawless, A Blueprint for Unified Omnichannel in Pharma

    Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the blueprint for a truly unified and...

    Impetus Digital

    - PMLiVE

    Patient Recruitment in Oncology: A Phase III Melanoma Case Study

    Boosting screening & enrollment rates in a global oncology trial

    Innovative Trials

    2025 T40 open for submissions
    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links